Work

In patients with chronic heart failure which polypharmacy pheno-groups are associated with adverse health outcomes? (Polypharmacy pheno-groups and heart failure outcomes)

Year: 2023

Type: article

Study design: Observational Study

Source: Current Problems in Cardiology

DOI: 10.1016/j.cpcardiol.2023.102194

Authors: Mohammed Ibn-Mas'ud Danjuma, Aseel Abdulrahim Sukik, Ahmed Tarek Aboughalia, Mubarak Bidmos, Yousra Ali, Reem Chamseddine, Abdelnaser Elzouki, Oyelola Adegboye

Institutions: NHS Grampian, Hamad General Hospital, Dr Gray's Hospital, Weill Cornell Medical College in Qatar, Hamad Medical Corporation, Qatar University, Charles Darwin University, Menzies School of Health Research

Language: English

Topic: Pharmaceutical Practices and Patient Outcomes

Subfield: Geriatrics and Gerontology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4388798352

FWCI: 1.254

Cites: 25

Cited by: 8

Related to: 10